Company: BIAF
Filing Date: 2025-04-22
Form Type: 424B3
Source: 0001641172-25-005598
Chunk: 12

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-22
Form: 424B3
Chunk 12
---
 documents and under Delaware law could 
 make an acquisition of the Company more difficult.                         |

| ● | Provisions in our Charter and Amended and Restated (“A&R”)            
 Bylaws could make a merger, tender offer, or proxy contest difficult. |

| ● | Certain provisions of Delaware’s General Corporation Law (“DGCL”) 
 may have anti-takeover effects.                                   |

| ● | Our Charter designates Delaware state or federal courts as the exclusive 
 forum for disputes.                                                      |

| ● | Provisions in our Charter and A&R Bylaws may discourage stockholders 
 from bringing a lawsuit against our directors and officers.          |

| ● | Our management collectively owns a substantial percentage of our Common Stock. |

| ● | If analysts publish unfavorable research, or none at all, about our business, 
 our stock price and trading volume could decline.                             |

| ● | Any                                                                                               
 inability to report and file our financial results accurately and timely could harm our business. |

| 4 |

<div align='center'>THE OFFERING</div>

This prospectus relates to the resale or other disposition
from time to time by the Selling Stockholders identified in this prospectus of up to 3,013,951 shares of our Common Stock. None of the
shares registered hereby are being offered for sale by us.

| Shares of Common Stock offered by the Selling Stockholders |     | 3,013,951 shares of Common Stock, consisting of: (i) 2,926,166 shares of Common Stock issuable upon the exercise of the Inducement Warrants; and (ii) 87,785 shares of Common Stock issuable upon the exercise of the Advisor Warrants                                                                                                                                                                                                                                                                                                                                                                  |
| Common stock to be outstanding after this offering(1)      |     | 21,262,574                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
 shares of Common Stock, assuming the exercise of all of the Common Warrants                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Registration Rights                                        |     | Under the terms of the Inducement Agreement,                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
 we agreed to file this registration statement with respect to the registration of the resale by the Holders of the Inducement Warrant                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
 Shares by the 45th calendar day following the date of the Inducement Agreement. In addition, we agreed that, upon the registration statement                                                                                                                                                                                                                                                                                                                                                                                                                                                            
 being declared effective under the Securities Act, we will use commercially reasonable efforts to maintain the effectiveness of the registration